Healthcare >> CEO Interviews >> December 14, 1998

Christopher Mirabelli – Leukosite Inc (lkst)

DR. Christopher MIRABELLI has served as Chairman of the Board of Directors, President and Chief Executive Officer since July 1993. Dr. Mirabelli was a founder of Isis Pharmaceuticals, Inc., a biotechnology company, where he served as Executive Vice President from 1992 to 1993, Senior Vice President of Research and Preclinical Development from 1991 to 1992, and Vice President of Research from 1989 to 1991. From 1981 to 1989, Dr. Mirabelli served in various positions at SmithKline & French Laboratories, most recently as Director of Molecular Pharmacology. Dr. Mirabelli received his B.S. in Biology from the State University of New York at Fredonia and his Ph.D. in Pharmacology from Baylor College of Medicine. Profile
TWST: Please give us an overview of LeukoSite, your history, your

activities, your products?

Dr. Mirabelli: LeukoSite, is an emerging pharmaceutical company based on

an R&D platform that